We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer

This study has been terminated.
(See Detailed Description)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00102895
First Posted: February 4, 2005
Last Update Posted: August 27, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Pfizer
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2005
  Primary Completion Date: No date given